Cost Per Reportable Test Hematology Analyzer Lease

Past Recompete Updated

Agency
Solicitation expected
Estimated value
$25,000 to $250,000
Set-aside
No set-aside

Forecast facts

Incumbent contract
Anticipated award
NAICS code
926150 Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Indian Health Service is conducting a recompete to procure cost-per-reportable-test hematology analyzer lease services to provide diagnostic blood tests supporting the diagnosis and treatment of various illnesses and conditions. The solicitation is estimated to release on September 1, 2026, with award anticipated on November 1, 2027. No small business set-aside applies to this procurement.

The estimated award value ranges from $25,000 to $250,000. Performance will occur at various locations throughout the Great Plains Area. Ladonna Collins, Contracting Officer, and Wanda Dally, Lab Supervisor at Wagner Healthcare Center, are listed as points of contact.

Sysmex America, Inc. holds the incumbent delivery order V797D40235-75H70621F80183, a base plus four option year contract for cost-per-reportable-result clinical laboratory services supporting Indian Health Service health care facilities throughout the Great Plains Area. The current modification exercises option year four, with a performance period from September 1, 2025, through August 31, 2026, and is valued at $1.18 million on a firm fixed price basis. The contract was awarded on September 7, 2021, and operates under the GSA Multiple Award Schedule contract FSS-66-III, Critical Analyzers, Laboratory.

Forecast text

To provide diagnostic blood (hematology) tests for various conditions in the diagnosis and treatment of various illnesses and conditions

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast